TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: students' general and specific attitudes toward drugs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: capability to resist peer pressure
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: estimated level of drug use by peers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Working capacity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Independence of living
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Percentage of patients requiring no morphine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of morphine-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction of p53 positive index in foveolar epithelium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of total labeling index of PCNA in gastric pits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of care improvements
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Quality of life (COPD assessment test)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of acute exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: abnormal neurodevelopmental outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Understanding of self-assessment pain scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Test-retest reliability of self-assessment scales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation between observational rating and self-assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Cholesterol/High Density Lipoprotein Ratio (TC/HDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Volume of Load (VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Good neurological outcome (modified Rankin scale score 0-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of hemorrhagic volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of LASIK-associated dry eye
Endpoint domain: Adverse events/effects
Primary endpoint: Need for postoperative cyclosporine A treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Left Ventricular Remodeling (LVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in rVAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of drug-related AEs at the application site
Endpoint domain: Adverse events/effects
Primary endpoint: middle cerebral artery blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: posterior cerebral artery blood flow velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: gastro-intestinal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Plasma triacylglycerols (TAG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: symptom control of heartburn and acid regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: peak flexion angles during the SH task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee flexion angles for the side-cut task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee flexion angles for the SH task after a reminder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quitting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overall eradication rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Histamine concentration in nasal lavage fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality-Adjusted Life Year (QALY)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean change in LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Graft rupture rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Tegner activity scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Single Assessment Numeric Evaluation scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Conjunctivitis symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the repeat test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Score on the 14-item checklist
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attempts to find the vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Propulsion speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of dementia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Serum OVA-sIgE levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: OPN protein and mRNA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IMT (Intima-Media Thickness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Plasma CRP and IL-6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: long-term pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Colonization rate with ESBL‐E
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Support for the use of corporal punishment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: maximal ankle dorsiflexion improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: passive ankle range increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hazard Ratio (HR)
Endpoint domain: Mortality/survival
Primary endpoint: Uptake of cervical cancer screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Improved verbal learning and memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: empathy ratings
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: interrater reliabilities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: root caries status improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follow-up time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of sensor parameters reprogrammed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Threshold adjustment frequency
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Creatinine clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: eradication of bacterial pathogens (cure or presumed cure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Color changes (ΔE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PIDAQ scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pre-term birth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: increase of state anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: correct coincidence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to catheter expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: mean improvement of maximal swim time for 100 m
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in swim time relative to personal best time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement in average International Swimming Federation points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in magnitude of keratometric astigmatism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Mean magnitude of surgically induced astigmatism (SIA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Rate of AF recurrences
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of patients with >/= 1 asymptomatic AF episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Grade 1-3 bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Thromboembolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stomal necrosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Oedema rate
Endpoint domain: Adverse events/effects
Primary endpoint: Congestion rate
Endpoint domain: Adverse events/effects
Primary endpoint: Re-admission rate
Endpoint domain: Adverse events/effects
Primary endpoint: Breastfeeding duration at 12 weeks postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maternal satisfaction with partner involvement in breastfeeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Confidence in diagnosing CN abnormalities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in N1 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in N3 sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seizure freedom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VIP pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of safety equipment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe practices in storage of sharp objects
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe practices in storage of medicines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year change in lumbar spine BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Hyperstimulation with non-reassuring cardiotocography (CTG)
Endpoint domain: Adverse events/effects
Primary endpoint: Hepatic C13 cortisol production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Suppression of endogenous glucose production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: short-term morbidity
Endpoint domain: Mortality/survival
Primary endpoint: mean blood glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Median recovery time of the train-of-four ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: amount of retinal detachment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: number of retinal defects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: time needed to remove the foreign body
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reduction in harsh discipline practices
Endpoint domain: Life impact
Endpoint subdomain: Parenting practices
Primary endpoint: increase in positive and supportive parenting
Endpoint domain: Life impact
Endpoint subdomain: Parenting practices
Primary endpoint: decline in poor monitoring
Endpoint domain: Life impact
Endpoint subdomain: Parenting practices
Primary endpoint: Postoperative hospital stay duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with mean potassium <5.1 mEq/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stone-free rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of SLE flares
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's global assessment of disease activity
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of rheumatoid arthritis (RA)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of seropositive rheumatoid arthritis
Endpoint domain: Mortality/survival
Primary endpoint: SOT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average total AUDIT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced speed during dual task walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Energy intake reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Se levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Plasma GSH-Px levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rates
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distance walked in the 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician assessed PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall severity of mental symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Association between renal disease and PPI use
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Leisure activity levels
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Parental guess accuracy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with 'excellent' scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rebound spasm occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Good CPAP compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal Bone Loss (MBL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global cerebral blood flow (CBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: vein graft patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Lumbar spine bone mineral density (LSBMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean post-stabilization temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE proportion
Endpoint domain: Mortality/survival
Primary endpoint: Coronary artery spasm induction rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: discontinuation rate due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevention of HD graft stenosis and thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Constitutive release of IL-4 and IL-10 by CD4+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: INFgamma release by mitogen-stimulated CD4+ cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: PBMC constitutive production of IL-12 and IL-18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: HIV infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Gonorrhea infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Chlamydia infection rate
Endpoint domain: Adverse events/effects
Primary endpoint: Symptom frequency and degree alleviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stabilization scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CCK‐4‐induced maximum increase in heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CD25 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with labor care
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BACS composite score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fear of Falls self‐reported questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Plasma 5-HT concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma 5-HIAA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma KA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cpmax) of levobupivacaine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cpmax) of fentanyl
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum plasma concentration (Cpmax) of clonidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of suspected sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: cases of culture-proven sepsis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: deaths with clinical or culture-proven sepsis
Endpoint domain: Mortality/survival
Primary endpoint: mental flexibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: cognitive processes
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hospital-acquired pressure injuries (HAPIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Rosen score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline subjective average appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intracranial compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CSF outflow conductance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hepatic CYP3A activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentration ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported understanding
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Helpfulness of multimedia module
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GDS score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BDI score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: BAI score improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Volumetric reduction of grafts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: length of QS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: minimum amplitudes of QS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction of propofol requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suppression of auditory evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Detection of cerebral aneurysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Diagnosis of aneurysmal SAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in left temporal lobe gray matter volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Verbal fluency scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tramadol consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No serious adverse events attributable to the intervention
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients requiring analgesic rescue
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Asthma-related ED visits per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Asthma-related hospitalizations per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coding skill improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes